Formoterol FumarateThird Party Manufacturing in India

Formoterol Fumarate works by acting as a highly selective beta2-adrenergic receptor stimulant, which induces smooth muscle relaxation throughout the bronchial tree. It activates adenyl cyclase, the enzyme that catalyzes the conversion of ATP to cyclic AMP, decreasing intracellular calcium levels and stopping smooth muscle contraction. Unlike other long-acting bronchodilators, it possesses an exceptionally fast onset of action within one to three minutes while maintaining a twelve-hour therapeutic duration. It is highly effective and well-tolerated when paired with appropriate anti-inflammatory agents. Growing market traction makes Formoterol Fumarate third party manufacturing in India a strategic investment for commercial pharma portfolios. The material substance is tracked globally via CAS number 43229-80-7.

Therapeutic Uses

• Reversible Airways Obstruction: Long-term prevention of bronchospasm in patients with nocturnal or daytime asthma.
• COPD Management: Maintenance therapy to relieve continuous airflow limitations in chronic bronchitis patients.

Why Manufacturers Choose Formoterol Fumarate

Celesta Healthcare assists your sourcing requirements by executing technical transfers with advanced manufacturing plants. Our partner facilities are WHO-GMP certified, meaning they undergo strict testing for substance purity and delivery mechanics. Establishing a contract with a Formoterol Fumarate third party manufacturer in India ensures a streamlined market launch.